BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions

Topic: Disease mechanisms in lab and animal studies

A transmembrane aspartyl protease termed beta-site APP cleavage enzyme 1 (BACE1) that cleaves the amyloid-beta precursor protein (APP), which is abundant in neurons, is required for the generation of amyloid-beta (Abeta) peptides implicated in the pathogenesis of Alzheimer's disease (AD). We now demonstrate that BACE1, enriched in neurons of the CNS, is a major determinant that predisposes the brain to Abeta amyloidogenesis. The physiologically high levels of BACE1 activity coupled with low levels of BACE2 and alpha-secretase anti-amyloidogenic activities in neurons is a major contributor to the accumulation of Abeta in the CNS, whereas other organs are spared. Significantly, deletion of BACE1 in APPswe;PS1DeltaE9 mice prevents both Abeta deposition and age-associated cognitive abnormalities that occur in this model of Abeta amyloidosis. Moreover, Abeta deposits are sensitive to BACE1 dosage and can be efficiently cleared from the CNS when BACE1 is silenced. However, BACE1 null mice manifest alterations in hippocampal synaptic plasticity as well as in performance on tests of cognition and emotion. Importantly, memory deficits but not emotional alterations in BACE1(-/-) mice are prevented by coexpressing APPswe;PS1DeltaE9 transgenes, indicating that other potential substrates of BACE1 may affect neural circuits related to emotion. Our results establish BACE1 and APP processing pathways as critical for cognitive, emotional, and synaptic functions, and future studies should be alert to potential mechanism-based side effects that may occur with BACE1 inhibitors designed to ameliorate Abeta amyloidosis in AD.

Key findings

• Significantly, deletion of BACE1 in APPswe;PS1DeltaE9 mice prevents both Abeta deposition and age-associated cognitive abnormalities that occur in this model of Abeta amyloidosis.
• Our results establish BACE1 and APP processing pathways as critical for cognitive, emotional, and synaptic functions, and future studies should be alert to potential mechanism-based side effects that may occur with BACE1 inhibitors designed to ameliorate Abeta amyloidosis in AD.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1523/jneurosci.2766-05.2005
• PubMed: 16354928
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{laird2005-16354928,
  author  = {Laird, F. M. and Cai, H. and Savonenko, A. V. and Farah, M. H. and He, K. and Melnikova, T. and Wen, H. and Chiang, H. C. and others},
  title   = {{BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2005},
  doi     = {10.1523/jneurosci.2766-05.2005},
  pmid    = {16354928},
  url     = {https://doi.org/10.1523/jneurosci.2766-05.2005}
}

Related studies in Disease mechanisms

• Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions Biological psychiatry · 2014-10-29 · usefulness score 38/100
• Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction The Journal of biological chemistry · 2021-02-09 · usefulness score 41/100
• Near infrared light decreases synaptic vulnerability to amyloid beta oligomers Scientific reports · 2017-11-08 · usefulness score 39/100
• Selective neuronal vulnerability to oxidative stress in the brain Frontiers in aging neuroscience · 2010-03-30 · usefulness score 40/100
• An epigenetic blockade of cognitive functions in the neurodegenerating brain Nature · 2012-02-29 · usefulness score 45/100
• Selective induction of calcineurin activity and signaling by oligomeric amyloid beta Aging cell · 2008-09-08 · usefulness score 36/100

Similar studies

• The β-Secretase BACE1 in Alzheimer's Disease 2021 · Risk genes beyond APOE
• BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome 2006 · Down syndrome and Alzheimer's
• A cellular complex of BACE1 and γ-secretase sequentially generates Aβ from its full-length precursor 2019 · Biomarkers
• The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans 2015 · Treatments
• Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease 2024 · Biomarkers
• The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice 2007 · Risk factors

More on Disease mechanisms

• A review that covers this ground Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists Journal of Alzheimer's disease : JAD · 2002-06-01 · usefulness score 36/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →